March 9

ZUG, Switzerland, March 9, 2011 - NovaShunt AG, a private Swiss medical device company with innovative fluid management technologies, announced today that it has raised CHF 23.7 million (about $25 million) in a Series B preferred share financing round co-led by BioMedInvest AG, Entrepreneurs Fund and Capricorn Health-tech Fund. Existing investors, NeoMed and VI Partners, were also significant participants in the new financing and NeoMed retains its role as the lead investor and largest shareholder of NovaShunt.

UK consumers more willing to pay premium for electric cars than European counterparts, according to new Deloitte study

BEERSE, Belgium, March 9, 2011 - Janssen-Cilag International NV today announced that XEPLION(R) (paliperidone palmitate), a once monthly, long-acting injectable, antipsychotic, has received approval from the European Commission for the treatment of schizophrenia.

PARIS, March 9, 2011 - At an Investor Day event held today in Paris, Valeo is presenting its new medium-term guidance.

ISTANBUL, March 9, 2011 - Turkcell (NYSE:TKC, ISE: TCELL), the leading communications and technology company in Turkey is delighted to announce its 100% owned subsidiary and Turkey's leading internet service provider Superonline's fast entrance to the "fiber-to-the-home" league. Superonline was a key contributor in helping place Turkey 8th on the list of fiber internet penetration among G20 countries, according to the International Fiber-to-the-Home (FTTH) Council's latest report.